Psychopharmacology 2020

October 22, 2020 to October 25, 2020

Now Virtual! 

Engage the experts. Get your questions answered.

This psychiatry conference examines the latest research and treatment advances across dozens of mental health conditions. It offers in-depth information that is important for all mental health and primary care settings. Topics include ADHD, anxiety, bipolar disorder, depression, OCD, psychosis, PTSD, substance use disorders, and much more.

In every session, our faculty share any data from new clinical trials. They match it up against prior data and discuss what the changes mean. They also examine standards of care and share innovative ways to make care better. The agenda touches on many complex topics in mental health. Managing side effects, drug interactions, natural medications, combining pharmacologic and psychosocial treatments, and much more.

Most important of all, our faculty focus on how to translate all these insights into your daily practice. This empowers you to optimize your care for patients with psychiatric conditions. That makes our event ideal for professionals in psychiatry, primary care, psychology, and nursing.
 

NOTE:

If you purchased the bundled admission to Women's Mental Health and Psychopharmacology 2020 you must complete the evaluations for both events in order to claim all credit. The Women’s Mental Health course has been pre-loaded into your account. You may access the evaluation and your certificate for that conference at the link below:

lms.mghcme.org/wmhlive 

Pricing

3-DAY PSYCHOPHARMACOLOGY CONFERENCE

MDs/Doctoral-Level Professionals
Early Bird Registration (on or before September 4, 2020): $649.00
Regular Registration (after September 4, 2020): $699.00 

Other Professionals or Trainees
Early Bird Registration (on or before September 4, 2020): $409.00 
Regular Registration (after September 4, 2020): $459.00

THURSDAY SESSIONS

Registration for the Thursday evening sessions is now closed.

Please contact The Psychiatry Academy with any questions at mghcme@mgh.harvard.edu

Thursday Evening Sessions (October 22): $175
Choose between the following topics:

  • Law and Psychiatry
  • Psychosomatic Medicine/Consultation-Liaison Psychiatry
  • The Neuroscience Revolution: How will it Affect Patient Care?

Women’s Mental Health: $250 
If you are interested in attending the Women's Mental Health session ONLY, you can register for it by clicking here
This is a full day program that precedes the Psychopharmacology program and offers an additional 6.25 of CME/CEU credits.

PSYCHOPHARMACOLOGY AND WOMEN’S MENTAL HEALTH BUNDLED PRICING (SAVINGS OF $50)

MDs/Doctoral-Level Professionals
Early Bird (on or before September 4, 2020) = $849
Regular Registration (after September 4, 2020) = $899

Other Professionals or Trainees 
Early Bird (on or before September 4, 2020) = $609
Regular Registration (after September 4, 2020) = $659

 

Syllabus

Price: $48.00
Available for purchase on or before September 24, 2020

The conference syllabus is a printed book with all slide presentations and space to take notes adjacent to each slide.

As an alternative to purchasing a conference syllabus, we provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees.

IMPORTANT: PLEASE NOTE –  The syllabus cost does not include the additional shipping fee.

Due to the size and weight of the book, we will calculate a shipping fee based on your location. The estimate from the printer is approximately $15-$25 per book within the United States. Please contact our customer service team at mghcme@mgh.harvard.edu or (866) 644-7792 if you have questions about your shipping cost estimate.

If you purchase the syllabus, please verify during registration that we may charge the credit or debit card you register with for the shipment cost.

Cancellation Policy

A refund minus a $100.00 administrative fee will be issued for refund requests received by October 1, 2020.  No refunds will be issued for refund requests made after October 1, 2020. Payments made may not be applied to future conferences or other educational activities.  There are no exceptions to these policies.

Target Audience

This program is intended for:

Psychiatrists
Psychologists
General and Family Practice Physicians
Psychiatric Nurses
Physician Assistants
Nurse Practitioners
Social Workers

Learning Objectives

Our conference lets you engage dozens of renowned clinician-researchers, get your clinical questions answered, and translate enhanced knowledge into optimal patient care.

Here are some of the ways that participants plan to change their clinical practice as a result of attending our conference:

  • Identify rational, evidence-based pharmacologic and non-pharmacologic therapies for patients with unipolar, bipolar, treatment-resistant, and post-partum depression.
  • Assess obstacles to maintenance of long-term recovery and the liability issues associated with psychopharmacology.
  • Discuss diagnostic and evidenced-based treatment strategies for pediatric onset mood disorders.
  • Compare the neurobiology and evidence-based treatment approaches to addiction, anxiety, schizophrenia, and mood disorders.
  • Review the course and treatment of psychiatric disorders during pregnancy and menopause.
  • Recognize psychosocial issues and evidence-based treatment modalities for eating and sleep disorders.
  • Analyze drug interactions and the pharmacotherapy of adult ADHD and geriatric disorders.
  • Focus on reducing side effects of medication
  • Apply newer strategies in treatment of chemical abuse/dependence
  • Explain more succinctly why to choose a particular medication for a person
  • Explain more clearly how medications affect behaviors and mood
  • Use more evidence-based treatment for psychiatric illness
  • Move to augmentation strategies sooner
  • Screen patients for presence of substance use disorders, especially nicotine and alcohol
  • Renew a collaborative relationship with specialists to begin assisting in performing medication renewals
  • Include newly researched alternatives for augmentation treatment in refractory patients
  • More confidently weigh risks and benefits of treating vs. not continuing treatment during pregnancy
  • Be more cautious associating medications
  • Improve ability to convey to patients the range of treatment options
  • Better evaluate whether medication is needed and consider alternative treatments
  • Institute adjunctive medications that were not thought of previously
  • Follow new algorithms for treatment of bipolar disorder, major depression and schizophrenia
  • Integrate more augmentation strategies and increase use of maintenance ECT
  • Inform patients and colleagues of the most recent state-of-the-art alternatives
  • Take a more substantial sleep history
  • Consider problems that are causing difficulties with cognition, mood, and anxiety
  • Try natural remedies for treatment of depression
  • Educate patients more thoroughly with recent study results
  • Provide patients with more focused and comprehensive discussions regarding and symptom complexes
  • Be more knowledgeable and complete when referring patients
  • Develop a plan to use CBT based techniques
  • Change approaches related to maintenance treatment of bipolar disorder and treatment of mood disorders during pregnancy
  • Thoroughly discuss with patients how current available treatments work and increase medication adherence
Course summary
Available credit: 
  • 29.75 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.

    McLean Hospital designates this Live activity for a maximum of 29.75 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

  • 29.75 Nursing Contact Hours

    Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.

    This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 29.75 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.

  • 29.50 Social Workers

    The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers

    This program has been approved for 29.50 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D81571

  • 29.75 Participation

    This course allows other providers to claim a Participation Certificate upon successful completion of this course.

    Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.

  • 29.75 Psychologists CE Credit

    The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.

    This offering meets the criteria for 29.75 Continuing Education (CE) credits per presentation for psychologists.

Registration opens: 
06/01/2020
Course closes: 
07/29/2023
Event starts: 
10/22/2020 - 4:00pm EDT
Event ends: 
10/25/2020 - 5:00pm EDT
Cost:
$699.00
Add to calendar: 
Rating: 
0

Psychopharmacology Agenda

 

Content and faculty subject to change.

THURSDAY, OCTOBER 22, 2020 

4:00 - 8:00PM

Law and Psychiatry
THIS IS A TICKETED EVENT
Christine A. Darsney, PhD, Matthew Lahaie, MD, JD, Judith Edersheim,MD, JD, Rebecca Brendel, MD, JD

4:00 - 8:00PM

Psychosomatic Medicine/Consultation-Liaison Psychiatry
THIS IS A TICKETED EVENT
Christopher M. Celano, MD, Theodore A. Stern, MD, Nicholas Kontos, MD, Franklin King, MD

4:00 - 8:00PM

The Neuroscience Revolution: How will it Affect Patient Care?
THIS IS A TICKETED EVENT
Tracy Barbour, MD; Randy Buckner, PhD; Thomas McCoy, MD; Joshua Roffman, MD

FRIDAY, OCTOBER 23, 2020 

 

 

8:00 - 8:30AM

Welcoming Remarks & Introduction  
Maurizio Fava, MD & Jerrold F. Rosenbaum, MD 

Module Topic - Mood Disorders

8:30 - 9:15AM

Bipolar Depression
Andrew A. Nierenberg, MD

9:15 - 10:00AM

Bipolar Long-Term Management
Roy H. Perlis, MD, MSc

10:00 - 10:15AM

Break

10:15 - 11:00AM

Treatment Resistant Depression
Maurizio Fava, MD

11:00 - 12:00PM

Panel Discussion
Moderator: Jerrold F. Rosenbaum, MD
Panelists: Andrew A. Nierenberg, MD, Roy H. Perlis, MD, MSc, Maurizio Fava, MD 

12:00 - 1:00PM

Break

Module Topic - Anxiety/PTSD

1:00 - 1:45PM

PTSD
Eric Bui, MD. PhD & Luana Marques, PhD

1:45 - 2:30PM

Anxiety Disorders and Treatments
Jerrold Rosenbaum, MD 

2:30 - 3:15PM

Panel Discussion
Moderator: Jerrold Rosenbaum, MD
Panelists: Eric Bui, MD. PhD & Luana Marques, PhD

3:15 - 3:30PM

Coffee Break

Module Topic - Women's Health

3:30 - 4:10PM

Course and Treatment of Mood and Anxiety Disorders During Pregnancy
Lee S. Cohen, MD 

4:10 - 4:40PM

Postpartum Mood Disorders
Marlene P. Freeman, MD 

4:40 - 5:30PM

Panel Discussion
Moderator: David H. Rubin, MD
Panelists: Lee S. Cohen, MD, Marlene P. Freeman, MD 

5:30 - 6:30PM

Break

6:30 - 7:30PM
7:30 - 8:30PM

Friday Evening Seminars:

Natural Medications for Psychiatric Disorders*
David Mischoulon, MD, PhD

Suicide*
Theodore A. Stern, MD

The Neurobiology of Addiction*
Jodi Gilman, PhD

Psychopharmacology of Sleep Disorders*
John W. Winkelman, MD, PhD

The Neurobiology of Mood and Psychotic Disorders*
Daphne J. Holt, MD, PhD

Cognitive-Behavioral Therapy to Augment Psychopharmalogical Therapy*
Michael W. Otto, PhD

Psychedelic Medicine*
Franklin King, MD

*All Friday and Saturday evening sessions will be pre-recorded to allow all attendees access to each session.

SATURDAY, OCTOBER 24, 2020 

 

 

8:00 - 8:15AM

Welcoming Remarks & Introduction
David H. Rubin, MD

Module Topic - Psychosis

8:15 - 9:00AM

First-Episode Psychosis and Schizophrenia
Oliver Freudenreich, MD, FACLP

9:00 - 9:45AM

Management of Side-Effects of Antipsychotics
Oliver Freudenreich, MD, FACLP

9:45 - 10:00AM

Break

Module Topic - KETAMINE & ESKETAMINE

10:00 - 10:45AM

Ketamine and Esketamine: From Research to Clinical Practice
Cristina Cusin, MD

10:45 - 11:45AM

Panel Discussion
Moderator: David H. Rubin, MD
Panelists: Oliver Freudenreich, MD, FACLP, Cristina Cusin, MD

11:45 - 1:00PM

Break

Module Topic - New Therapies: What is on the Horizon?

1:00 - 1:45PM

Stimulation and/or Surgical Approaches to Psychiatric Illness
Joan Camprodon, MD, PhD 

1:45 - 2:30PM

New Treatments for Schizophrenia
Oliver Freudenreich, MD, FACLP

2:30 - 2:45PM

Break

2:45 - 3:30PM

New Treatments for Mood Disorders
Michael E. Henry, MD

3:30 - 4:15PM

What is New in Addiction?
John F. Kelly, PhD

4:15 - 5:15PM

Panel Discussion
Moderator: David H. Rubin, MD
Panelists: Michael E. Henry, MD, John F. Kelly, PhD 

5:15 - 6:30PM

Break

6:30 - 7:30PM

Saturday Evening Seminars:

Violence Risk Assessment in Clinical Practice*
Ronald Schouten, MD, JD, Lieutenant Frederick Cabral

Geriatrics*
Feyza E. Marouf, MD

Traumatic Brain Injury: A Neuropsychiatric Perspective*
Kaloyan S. Tanev, MD

Illuminating the Black Box: Antidepressants, Youth and Suicide*
David H. Rubin, MD

PMDD and Depression During the Menopausal Transition: New Insights*
Ruta Nonacs, MD

*All Friday and Saturday evening sessions will be pre-recorded to allow all attendees access to each session.

SUNDAY, OCTOBER 25, 2020 

 

 

7:45 - 8:00AM

Welcoming Remarks & Introduction
David H. Rubin, MD

Module Topic - Addiction

8:00 - 8:45AM

Alcohol and Opiates
Vinod Rao, MD, PhD

8:45 - 9:30AM

Tobacco and Cocaine
A. Eden Evins, MD, MPH

9:30 - 10:00AM

Panel Discussion
Moderator: David H. Rubin, MD
Panelists: A. Eden Evins, MD, MPH, Vinod Rao, MD, PhD

10:00 - 10:15AM

Break

Module Topic - OCD

10:15 - 11:00AM

OCD
Michael A. Jenike, MD 

11:00 - 11:45AM

Obsessive-Compulsive Related Disorders
Lisa M. Zakhary, MD, PhD 

11:45 - 12:15PM

CBT for OCD
Sabine Wilhelm, PhD 

12:15 - 12:45PM

Panel Discussion
Moderator: Michael A. Jenike, MD
Panelists: Lisa M. Zakhary, MD, PhD, Sabine Wilhelm, PhD  

12:45 - 1:45PM

Break

Module Topic - Across the Lifespan

1:45 - 2:30PM

Pediatric Bipolar Disorder and Mood Disorders
Janet Wozniak, MD

2:30 - 3:15PM

ADHD
Joseph Biederman, MD

3:15 - 3:30PM

Break

3:40 - 4:15PM

Drug Interactions
Jonathan E. Alpert, MD, PhD

4:15 - 4:45PM

Panel Discussion
Moderator: Joseph Biederman, MD
Panelists: Jonathan E. Alpert, MD, Janet Wozniak, MD 

4:45PM

Adjourn

 

Psychiatric Disorders in Women Agenda

Content and faculty subject to change.
 

THURSDAY, OCTOBER 22, 2020 

 

 

8:00 - 8:15AM

Welcome & Introduction
Marlene Freeman and Lee Cohen

8:15 - 8:45AM

Major Depressive Disorder in Pregnancy and the Postpartum
Lee S. Cohen, MD

8:45-9:15 AM

Bipolar Disorder: Considerations Across the Reproductive Lifespan
Marlene P. Freeman, MD

9:15-10:00 AM

Q&A
Lee S. Cohen, MD, Marlene P. Freeman, MD

10:00-10:15 AM

Break

10:15-10:45 AM

PMDD
Laura Petrillo, MD

10:45-11:15 AM

The Menopausal Transition and Depression
Ruta Nonacs, MD, PhD

11:15-12:00 PM

Q&A
Laura Petrillo, MD & Ruta Nonacs, MD, PhD

12:00-1:00 PM

Break

1:00-1:30 PM

Substance Use Disorders and Posttraumatic Stress Disorder in Women of Reproductive Age
Edwin Raffi, MD, MPH

1:30-2:00 PM

ADHD in Women
Allison Baker, MD

2:00-2:30 PM

Psychotherapies for Perinatal Psychiatry
Rachel Vanderkruik PhD, MSc

2:30-3:15 PM

Q&A
Edwin Raffi, MD, MPH; Allison Baker, MD; Rachel Vanderkruik PhD, MSc

3:15-3:30 PM

Conclusion & Closing Remarks
Lee S. Cohen, MD & Marlene P. Freeman, MD

 

Speaker(s)

Jonathan Alpert

has no relevant financial relationships to disclose at this time.

Tracy Barbour, MD

has no relevant financial relationships to disclose at this time.

Joseph Biederman, MD

has no relevant financial relationships to disclose at this time.

Rebecca Brendel, MD, JD

has no relevant financial relationships to disclose at this time.

Randy Buckner

has no relevant financial relationships to disclose at this time.

Eric Bui, MD

has no relevant financial relationships to disclose at this time.

Fredrick Cabral

has no relevant financial relationships to disclose at this time.

Joan Camprodon, MD, PhD, MPH

has no relevant financial relationships to disclose at this time.

Christopher Celano

has no relevant financial relationships to disclose at this time.

Judy Edersheim, MD

has no relevant financial relationships to disclose at this time.

Maurizio Fava, MD

has no relevant financial relationships to disclose at this time.

Oliver Freudenreich, MD

has no relevant financial relationships to disclose at this time.

Jodi Gilman, MD

has no relevant financial relationships to disclose at this time.

Michael Henry, MD

has no relevant financial relationships to disclose at this time.

Daphne Holt, MD, PhD

has no relevant financial relationships to disclose at this time.

Michael Jenike

has no relevant financial relationships to disclose at this time.

John Kelly, PhD

has no relevant financial relationships to disclose at this time.

Franklin King, MD

has no relevant financial relationships to disclose at this time.

Matthew Lahaie, MD, JD

has no relevant financial relationships to disclose at this time.

Feyza Marouf, MD

has no relevant financial relationships to disclose at this time.

Luana Marques, MD

has no relevant financial relationships to disclose at this time.

Thomas McCoy, MD

has no relevant financial relationships to disclose at this time.

David Mischoulon, MD

has a financial relationship (Financial Support) with MGH Clinical Trials Network and Institute (CTNI);.
has a financial relationship (Professional Services) with Nordic Naturals, Heckel Medizintechnik GmbH;.

Andrew Nierenberg, MD

has no relevant financial relationships to disclose at this time.

Michael Otto

has no relevant financial relationships to disclose at this time.

Roy Perlis, MD, MSc

has no relevant financial relationships to disclose at this time.

Vinod Rao, MD, PhD

has no relevant financial relationships to disclose at this time.

Judith Restrepo

has no relevant financial relationships to disclose at this time.

Joshua Roffman, MD

has no relevant financial relationships to disclose at this time.

JErrold Rosenbaum

has no relevant financial relationships to disclose at this time.

David Rubin, MD

has no relevant financial relationships to disclose at this time.

Ronald Schouten, MD

has no relevant financial relationships to disclose at this time.

Theodore Stern, MD

has no relevant financial relationships to disclose at this time.

Kaloyan Tanev, MD

has no relevant financial relationships to disclose at this time.

John Winkelman, MD

has no relevant financial relationships to disclose at this time.

Lisa Zakhary, MD, PhD

has no relevant financial relationships to disclose at this time.

Available Credit

  • 29.75 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.

    McLean Hospital designates this Live activity for a maximum of 29.75 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

  • 29.75 Nursing Contact Hours

    Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.

    This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 29.75 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.

  • 29.50 Social Workers

    The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers

    This program has been approved for 29.50 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D81571

  • 29.75 Participation

    This course allows other providers to claim a Participation Certificate upon successful completion of this course.

    Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.

  • 29.75 Psychologists CE Credit

    The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.

    This offering meets the criteria for 29.75 Continuing Education (CE) credits per presentation for psychologists.

Price

Cost:
$699.00
Please login or register to take this course.